【出版时间及名称】：2010年1月巴西医疗行业研究报告
        【作者】：德意志银行
        【文件格式】：pdf
        【页数】：49
        【目录或简介】：

Table of Contents
Sector Investment Thesis ................................................................. 3
Our check-up points to healthy sector fundamentals................................................................3
The Brazilian healthcare landscape ................................................. 6
Revisiting the main sector trends and issues............................................................................6
OdontoPrev ...................................................................................... 12
Investment summary ..............................................................................................................12
Earnings outlook .....................................................................................................................14
Valuation ................................................................................................................................16
Risks ......................................................................................................................................16
Amil/Medial ..................................................................................... 19
Investment Summary..............................................................................................................19
Earnings outlook .....................................................................................................................20
Valuation ................................................................................................................................22
Risks ......................................................................................................................................23
DASA ................................................................................................ 25
Investment Summary..............................................................................................................25
Earnings Outlook.....................................................................................................................25
Valuation ................................................................................................................................27
Risks ......................................................................................................................................27
Fleury ................................................................................................ 29
Investment Summary..............................................................................................................29
Earnings outlook .....................................................................................................................29
Valuation ................................................................................................................................31
Risks ......................................................................................................................................31
Fleury under the microscope.......................................................... 33
Company Description .............................................................................................................33
Fleury’s Business Units...........................................................................................................33
Fleury’s Strategy/Restructuring...............................................................................................35
Acquisitions have been major driver in recent expansion .......................................................37
Fleury vs. DASA......................................................................................................................38
Shareholders’ Structure ..........................................................................................................41
Management..........................................................................................................................42
Appendix: Valuation Comps........................................................... 43